NCT03130790 2022-02-15
Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)
ASLAN Pharmaceuticals
Phase 2/3 Completed
Clinical Trials
8 trialsNCT03093870 2021-08-03
TreeTopp
ASLAN Pharmaceuticals
Phase 2/3 Completed
NCT00278902 2020-10-14
A Study of ARRY-334543 in Patients With Advanced Cancer
Array BioPharma
Phase 1 Completed
NCT00710736 2020-10-06
A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer
Array BioPharma
Phase 1 Completed
NCT00833326 2020-10-06
A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer
Array BioPharma
Phase 1 Completed
NCT02648425 2018-10-25
Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine
ASLAN Pharmaceuticals
Phase 1 Completed
NCT02609958 2018-05-29
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
ASLAN Pharmaceuticals
Phase 2 Completed
NCT00862524 2012-10-04
A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer
Array BioPharma
Phase 1/2 Completed